| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/03/2001 | EP1064393A1 Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| 01/03/2001 | EP1064392A2 Multigene vectors |
| 01/03/2001 | EP1064391A1 Antisense modulation of human mdm2 expression |
| 01/03/2001 | EP1064390A1 Enhanced anti-tumor immunity |
| 01/03/2001 | EP1064389A1 Kinase wee1 fusion protein compositions, nucleotide sequences, expression systems, and methods of use |
| 01/03/2001 | EP1064388A1 Human casb12 polypeptide, a serine protease |
| 01/03/2001 | EP1064387A2 $i(LIMANTHES) OIL GENES |
| 01/03/2001 | EP1064386A1 Improvements in or relating to fatty acid metabolism |
| 01/03/2001 | EP1064385A2 Plant control genes |
| 01/03/2001 | EP1064384A1 Signal transduction protein involved in plant dehiscence |
| 01/03/2001 | EP1064383A2 Interferon alpha plasmids and delivery systems, and methods of making and using the same |
| 01/03/2001 | EP1064382A2 Polypeptides homologous to vegf and bmp1 |
| 01/03/2001 | EP1064381A1 Cardiostatin polypeptides and polynucleotides |
| 01/03/2001 | EP1064380A1 EXPRESSION OF THE $i(INSL4) GENE IN HUMAN EMBRYONIC BONE TISSUES AND APPLICATIONS |
| 01/03/2001 | EP1064379A2 Human nucleic acid sequences from tissue of breast tumors |
| 01/03/2001 | EP1064378A2 Hypoxia-inducible human genes, proteins, and uses thereof |
| 01/03/2001 | EP1064377A1 Casb414: antigen overexpressed in several tumours |
| 01/03/2001 | EP1064376A2 GFR$g(a)3 AND ITS USES |
| 01/03/2001 | EP1064375A2 Human calcium-binding proteins |
| 01/03/2001 | EP1064374A1 Novel molecules expressed during muscle development and genetic sequences encoding the same |
| 01/03/2001 | EP1064373A2 Identification of factors which mediate the interaction of heterotrimeric g proteins and monomeric g proteins |
| 01/03/2001 | EP1064372A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/03/2001 | EP1064371A2 Isolated mammalian membrane protein genes and related reagents |
| 01/03/2001 | EP1064370A2 Protein phosphatase-related molecules |
| 01/03/2001 | EP1064369A2 Nucleic acid binding proteins |
| 01/03/2001 | EP1064368A1 Suppressors of cytokine signalling |
| 01/03/2001 | EP1064367A2 Production of biofilaments in transgenic animals |
| 01/03/2001 | EP1064366A1 $i(STAPHYLOCOCCUS AUREUS) GENES AND POLYPEPTIDES |
| 01/03/2001 | EP1064365A2 Expression of trehalose biosynthetic genes in plants |
| 01/03/2001 | EP1064364A1 The cytokine family member 2-21 |
| 01/03/2001 | EP1064363A1 Retroviral packaging cell line |
| 01/03/2001 | EP1064362A1 Nek1-related protein kinase |
| 01/03/2001 | EP1064361A1 Lcb2 subunit of serine palmitoyltransferase |
| 01/03/2001 | EP1064360A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 01/03/2001 | EP1064359A2 Phenol oxidizing enzyme enzymes |
| 01/03/2001 | EP1064358A2 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b |
| 01/03/2001 | EP1064354A1 Compositions and methods for gene-based vaccines to provoke t cell responses |
| 01/03/2001 | EP1064309A2 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue |
| 01/03/2001 | EP1064307A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof |
| 01/03/2001 | EP1064305A1 Recombinant virus |
| 01/03/2001 | EP1064304A2 Genes encoding mlo proteins and conferring fungal resistance upon plants |
| 01/03/2001 | EP1064303A1 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 01/03/2001 | EP1064301A1 Bacterial yael family members as targets for antimicrobial drug design |
| 01/03/2001 | EP1064297A1 95 human secreted proteins |
| 01/03/2001 | EP1064296A1 Thermostable dna polymerase from thermoanaerobacter thermohydrosulfuricus |
| 01/03/2001 | EP1064295A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS |
| 01/03/2001 | EP1064292A1 Photoactivatable nucleic acid derivatives |
| 01/03/2001 | EP1064022A1 Hla-binding peptides and their uses |
| 01/03/2001 | EP1064018A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 01/03/2001 | EP1064016A2 Compositions for modulating cell differentiation comprising a lipid and a morphogen |
| 01/03/2001 | EP1064015A2 Receptor derived peptides as modulators of receptor activity |
| 01/03/2001 | EP1064007A1 nrdG |
| 01/03/2001 | EP1064006A1 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
| 01/03/2001 | EP1064005A1 Urokinase plasminogen activator receptor as a target for diagnosis of metastases |
| 01/03/2001 | EP1063997A2 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 01/03/2001 | EP1063979A2 Plant cell cyclin genes |
| 01/03/2001 | EP1063891A2 Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby |
| 01/03/2001 | EP1063887A1 P53-dependent secretion of growth inhibitory factors |
| 01/03/2001 | EP1063880A1 Plant promoter sequences and methods of use thereof |
| 01/03/2001 | EP0910467B1 Electrochemical solid phase synthesis of polymers |
| 01/03/2001 | EP0828759B1 Process of high purity albumin production |
| 01/03/2001 | EP0816506B1 System for the expression of heterologous antigens as fusion proteins |
| 01/03/2001 | EP0807183B1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
| 01/03/2001 | EP0727046B1 Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease |
| 01/03/2001 | EP0706649B1 Method and apparatus for real time detection of nucleic acid amplification products |
| 01/03/2001 | EP0654093B1 Detecting and amplifying target nucleic acids using exonucleolytic activity |
| 01/03/2001 | CN1278868A Prediction of inflammatory disease associated with IL-1 genelocl polymorphisms |
| 01/03/2001 | CN1278867A A thermophilic alkaline phosphoesterase and its expression |
| 01/03/2001 | CN1278866A MPL ligand analogs |
| 01/03/2001 | CN1278865A Tumor-specific antigens, methods for their production and their use for immunization and diagnosis |
| 01/03/2001 | CN1278864A Genetically modified tumor-targeted bacteria with reduced virulence |
| 01/03/2001 | CN1278739A Method of delivering genes to antigen presenting cells of the skin |
| 01/03/2001 | CN1278736A Hmanized antibodies to human gp39, compositions containing and therapeutic use thereof |
| 01/03/2001 | CN1278701A Method for large scale mutagenesis in crop plants |
| 01/03/2001 | CN1278557A Human protein kinase inhibitor gamma and its code sequence, preparation and use |
| 01/03/2001 | CN1278556A Human montage factor II and its code sequence, preparation and use |
| 01/03/2001 | CN1278555A New human stroma cell protein and its code sequence |
| 01/03/2001 | CN1060216C Improved methods for the preparation of endotoxinbinding proteins |
| 01/03/2001 | CN1060215C Process for producing cytidine diphosphate choline |
| 01/03/2001 | CN1060214C Amidase gene and modifying application of its expressed active products to polypeptide amidating |
| 01/03/2001 | CN1060177C 3'-monophosphorylated oligonucleotides |
| 01/02/2001 | US6169232 Nucleotide sequences of genes encoding sink protein and uses thereof for improving the nutritional quality of feeds |
| 01/02/2001 | US6169226 Starch branching enzyme II of potato |
| 01/02/2001 | US6169194 High surface density covalent immobilization of oligonucleotide monolayers using a 1-(thiotrifluoroacetato)-11-(trichlorososilyl)-undecane linker |
| 01/02/2001 | US6169176 Synthesizing oligonucleotides having a backbone of alkyl or alkoxy thiourea linkages; antisense and gene therapy agents with increased affinity and nuclease resistance |
| 01/02/2001 | US6169175 Dna sequence encoding a variant m2 polypeptide of influenza a having a deletion of a domain, thus causing a reduction in hydrophobicity and an increase solubility in aqueous buffers |
| 01/02/2001 | US6169174 Dna coding for a protein of defined amino acid sequence which controls fiber formation; for improvements in textile, paper and food industries |
| 01/02/2001 | US6169173 Cloning and functional expression of cholecystokinin/gastrin receptor-encoding DNA |
| 01/02/2001 | US6169172 Chimeric protein of a protein of interest which is extended at amino-terminal with second defined amino acid sequence; for recombinant production in eukaryotic cells |
| 01/02/2001 | US6169169 PNA probes for detection of Neisseria gonorrhoeae and Chlamydia trachomatis |
| 01/02/2001 | US6169167 Antibodies to ligands for HEK4 receptors |
| 01/02/2001 | US6169079 An antisense oligonucleotides designed to hybridize to the mrna encoding intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, for treating inflammation |
| 01/02/2001 | US6169073 An oligopeptide or polypeptide for activating dna binding of wild-type p53 and select tumor-derived p53 mutants; use in therapy of cancer and other disorders characterized by excessive proliferation of certain cells and tissues |
| 01/02/2001 | US6169070 Mer receptor activation by gas6 |
| 01/02/2001 | US6169068 Treating lung disease or disorder by inhalating a protein |
| 01/02/2001 | US6168954 Amino acid sequences and nucleotide sequences; herbicide resistant transgenic plants; screening for enzyme inhibitors and substrates; probing cdna or genomic libraries |
| 01/02/2001 | US6168953 Increasing efficiency of viricide in host cell by contacting with vector derived from spumavirinae, spumavirus, lentivirinae, or lentivirus; vector contains a cis-acting genetic element which colocalizes the viricide with target |
| 01/02/2001 | US6168951 Plant geranylgeranyl transferases |
| 01/02/2001 | US6168950 Compound 8 to 30 nucleotides in length which specifically hybridizes and inhibits gene expression of human mitogen-activated protein kinase kinase kinase 1; anticarcinogenic/antiproliferative agents |
| 01/02/2001 | US6168946 gp75 as a tumor vaccine for melanoma |